| Health / Medical Topics |
HDAC inhibitor CG200745
A histone deacetylase (HDAC) inhibitor with potential antineoplastic activity. CG200745 inhibits the catalytic activity of HDAC, resulting in an accumulation of highly acetylated chromatin histones, followed by the induction of chromatin remodeling and an altered pattern of gene expression. In particular, this agent enhances the histone acetylation of the tumor suppressor gene p53. This results in an accumulation of p53, p53-dependent transactivation and apoptosis in tumor cells. HDAC, an enzyme upregulated in many tumor types, deacetylates chromatin histone proteins. (NCI Thesaurus)
YOU MAY ALSO LIKE
An orally bioavailable benzamide and inhibitor of human class I histone deacetylases (HDACs) isoenzymes 1, 2 and 3, with potential antineoplastic…
A substance that causes a chemical change that stops tumor cells from dividing. HDAC inhibitors are being studied in the treatment of…
An enzyme that removes a small molecule called an acetyl group from histones (proteins found in chromosomes). This changes the way the…
Bipartite DNA binding domain containing a homeo domain and a leucine zipper.
The NCI term type designation for a header term.
A virus that causes hepatitis (inflammation of the liver). It is carried and passed to others through the blood and other body…
